Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Agents causing non-A non-B hepatitis: could one be a prion?

H S Kingdon

    Medical Hypotheses
    |March 1, 1987
    PubMed
    Summary

    Non-A non-B hepatitis, transmitted via blood, requires distinct inactivation methods from the AIDS virus. Research suggests a unique infectious agent, potentially a prion, may cause this liver disease.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Issues with the assay of factor VIII activity in plasma and factor VIII concentrates.

    Thrombosis and haemostasis·2001
    Same author

    Molecular 'pharming'.

    Biotechnology and applied biochemistry·1999
    Same author

    Measurement of active coagulation factors in Autoplex-T with colorimetric active site-specific assay technology.

    Thrombosis and haemostasis·1998
    Same author

    A note on the calculation of recovery for factor VIII infusions.

    Thrombosis and haemostasis·1993
    Same author

    Treatment of hemophilia A with a highly purified factor VIII concentrate prepared by anti-FVIIIc immunoaffinity chromatography.

    Thrombosis and haemostasis·1992
    Same author

    A two-phase linear regression model for biologic half-life data.

    The Journal of laboratory and clinical medicine·1990

    Area of Science:

    • Hepatology
    • Infectious Diseases
    • Virology

    Background:

    • Non-A non-B hepatitis (NANBH) is a significant transfusion-transmitted infection.
    • The causative agent(s) of NANBH remain unidentified.
    • Current inactivation methods for other viruses do not effectively prevent NANBH transmission.

    Purpose of the Study:

    • To investigate the transmission routes of non-A non-B hepatitis.
    • To evaluate the efficacy of existing viral inactivation procedures against NANBH agents.
    • To explore potential novel infectious agents responsible for NANBH.

    Main Methods:

    • Analysis of laboratory and clinical data related to NANBH transmission.
    • Comparison of inactivation procedures for Human Immunodeficiency Virus (HIV) and NANBH agents.
    • Review of existing literature on infectious agents and hepatitis transmission.

    Main Results:

    • Procedures effective against the Human Immunodeficiency Virus (HIV) do not prevent non-A non-B hepatitis transmission.
    • Evidence suggests NANBH is caused by infectious agents distinct from those targeted by current safety protocols.
    • The possibility of a prion-like agent causing NANBH is raised.

    Conclusions:

    • Standard viral inactivation methods are insufficient for preventing non-A non-B hepatitis.
    • Further research is needed to identify the specific agent(s) responsible for non-A non-B hepatitis.
    • The hypothesis of a prion or similar unique agent warrants investigation for non-A non-B hepatitis etiology.

    Related Experiment Videos